Dihexa: What This Nootropic Peptide Is in 2026

Dihexa is a peptide studied for memory and brain-cell connection in animals. It comes from angiotensin IV and was built to boost a growth signal called HGF at its c-Met receptor, which helps neurons form new links. The dihexa research to date is animal and lab work, with no human trials on dihexa itself. pru does not offer dihexa today. For mood and calm, pru offers physician-prescribed oxytocin.

What is dihexa?

Dihexa is a small lab-made peptide studied for memory and learning in animals. Its chemical name is N-hexanoic-Tyr-Ile-(6) aminohexanoic amide, and its research code is PNB-0408. It comes from angiotensin IV, a natural signaling molecule. Researchers Joseph Harding and John Wright at Washington State University designed it to reach the brain and to switch on a growth pathway that helps neurons build new connections.

Dihexa is a research compound. It has been tested in mice and in cell studies, with no completed human trials on dihexa itself. It is often grouped with nootropic peptides like semax and selank, though it works through a different pathway.

How does dihexa work?

Dihexa is thought to work by boosting a natural growth signal in the brain. It binds to hepatocyte growth factor (HGF) and helps HGF act on its receptor, c-Met. This HGF/c-Met pathway is linked to synaptogenesis, the growth of new connections between neurons. More connections may support learning and memory, which is why the pathway draws research interest.

Studies in mice also point to a downstream chain called the PI3K/AKT pathway. In one Alzheimer's-model study, blocking PI3K removed dihexa's effects, which shows this pathway is central to how it acts. This work is in animals and cells.

• Origin: derived from angiotensin IV, a natural brain signaling molecule.
• Main target: binds HGF and boosts activity at the c-Met receptor.
• Studied effect: growth of dendritic spines and new synapses in animals.
• Downstream: activates PI3K/AKT signaling in mouse studies.
• Design goal: better brain penetration than the parent peptide.

What does the research on dihexa show?

The dihexa research is preclinical: rodent studies and lab assays, with no human trials on dihexa itself. In these animal studies, dihexa improved memory tasks and increased markers of new synapse growth. One widely cited lab assay reported dihexa was far more potent than BDNF, a key brain growth factor, at promoting neuron connections.

Is dihexa a good nootropic for focus and memory?

People call dihexa a nootropic because of its memory research in animals, where it acts on the brain's HGF/c-Met growth pathway to support new synapse formation. That research is in animals and cells, with no human focus or memory data on dihexa itself. The interest comes from strong animal results and a novel mechanism.

For readers comparing options, our guides to nootropic peptides and the best peptides for focus and memory cover peptides with more human data behind them. You can also browse the cognition, mood and sleep category to see what pru offers today.

How does dihexa compare to semax and selank?

Dihexa, semax, and selank are all studied for the brain, but they act differently and have different levels of evidence. Semax and selank have more human research, mostly from Russia, and are the ones under active regulatory review in the US. Dihexa sits further back: a novel mechanism, exciting animal data, and no human trials.

To go deeper on the alternatives, see the semax guide, the selank guide, and the cerebrolysin guide, another neuro-focused compound with a different profile.

Is dihexa safe? What are the side effects?

In animal research, dihexa acted powerfully on the brain's memory signaling, and human studies are the next step. Because it strongly drives cell-growth signaling, researchers note that pathway is worth studying carefully over the long term, since growth signals can act in more than one part of the body.

pru does not offer dihexa today because it is pending the FDA's February 2027 PCAC review and does not yet have a cleared, regulated compounding pathway. pru only works with peptides a licensed physician can prescribe and an FDA-registered 503A pharmacy can compound. Until dihexa reaches that kind of overseen, legitimate pathway, the sound move is to wait for it rather than order a research-only vial with no prescriber or pharmacy behind it.

• Pending PCAC review: dihexa is slated for the FDA's February 2027 PCAC review and has no cleared, regulated compounding pathway yet, so pru does not offer it.
• Animal-stage evidence: the strongest memory results so far come from animal research, with human studies the next step.
• Research-vial risk: a 'research only' vial comes with no prescriber, no pharmacy, and no verified contents.
• Not a treatment: dihexa is not approved to treat, cure, or prevent any condition.

Is dihexa legal, and where does it come from?

Today, dihexa is sold almost entirely as research-grade material. These vials are labeled "for research use only, not for human consumption," and they come with no prescriber and no pharmacy behind them. That is the real risk: no one is checking who you are, whether it fits you, or what is in the vial. Purity, dose, and sterility are not guaranteed on the grey market.

On the regulatory side, in April 2026 the FDA removed 12 peptides from its 503A Category 2 list, dihexa among them. The Pharmacy Compounding Advisory Committee (PCAC) reviews the first group on July 23-24, 2026, and takes up the rest, including dihexa, injectable GHK-Cu, and melanotan II, at a second meeting slated for February 2027.

Removal from Category 2 is not FDA approval, and dihexa does not have a cleared, regulated compounding pathway yet. That is the key reason pru does not offer it today, and pru would rather wait for that legitimate pathway than point you to a research-only vial.

How does pru handle dihexa and peptides like it?

pru is a telehealth platform for peptides done the careful way. Licensed physicians prescribe, and FDA-regulated 503A pharmacies compound and fill. You select the peptide you are interested in, and the physician confirms whether it fits you. Membership is about $50 a month, and peptides are sold separately at cost, itemized, with no markup.

pru does not offer dihexa. It is pending the FDA's February 2027 PCAC review and does not have a cleared, regulated compounding pathway yet, so it does not clear that bar today. In this cognition and mood cluster, the live pru product is physician-prescribed oxytocin, studied for mood, calm, and bonding.

Peptides like semax, DSIP, and epitalon are planned, pending the July 2026 FDA review, and pru is preparing to offer them the right way if that pathway opens. Reading up on a peptide like dihexa is already a proactive move for your brain health, and pru exists to make the careful, physician-backed version of that path the accessible one. You can see membership pricing or browse the full catalog whenever you are ready.

• Physician-prescribed: a licensed clinician confirms fit before anything is filled.
• Pharmacy-grade: compounded by FDA-regulated 503A pharmacies, not grey-market vials.
• At cost: peptides itemized with no markup, membership around $50 a month.
• Live now: oxytocin for mood, calm, and bonding.
• Planned: semax, DSIP, and epitalon, pending the July 2026 FDA review.

Related reading

Keep exploring peptides for the brain, focus, and mood with these guides.

• Nootropic peptides: a complete guide
• Best peptides for focus and memory
• Semax guide
• Selank guide
• Cerebrolysin guide
• Oxytocin benefits

Ready to look at what pru offers today? Browse the cognition, mood and sleep category or see oxytocin.

Common questions